PBD
Showing 1 - 25 of 60
Regenerative Medicine Trial in Lahore (PRP and PBD-VSEL Stem Cell therapy)
Completed
- Regenerative Medicine
- PRP and PBD-VSEL Stem Cell therapy
-
Lahore, Punjab, Pakistangull e Rukh
Nov 20, 2023
Patients With Peroxisome Biogenesis Disorders (PBD)
Recruiting
- Peroxisome Biogenesis Disorder
- +10 more
-
Montreal, Quebec, CanadaResearch Institute of the McGill University Health Center
Jul 4, 2022
Blasts 5 Percent or More of Bone Marrow Nucleated Cells, CD22 Positive, Philadelphia Chromosome Positive Trial in Monrovia,
Recruiting
- Blasts 5 Percent or More of Bone Marrow Nucleated Cells
- +4 more
- ADCT-602
-
Monrovia, California
- +1 more
Dec 7, 2022
Post-Transplant Lymphoproliferative Disorder, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Seattle
Not yet recruiting
- Post-Transplant Lymphoproliferative Disorder
- +10 more
- Loncastuximab Tesirine
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2022
Recurrent DLBCL, Recurrent Grade 3b Follicular Lymphoma, Recurrent High Grade B-Cell Lymphoma Trial in Duarte (Biopsy,
Not yet recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +11 more
- Biopsy
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 3, 2023
Lower Urinary Tract Symptoms, Voiding Disorders, Enuresis Trial in Belgium (Minze Diary Pod, Paper bladder diary)
Recruiting
- Lower Urinary Tract Symptoms
- +3 more
- Minze Diary Pod
- Paper bladder diary
-
Edegem, Antwerpen, Belgium
- +4 more
Oct 1, 2023
Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6
Withdrawn
- Recurrent Diffuse Large B-Cell Lymphoma
- +9 more
- Autologous Hematopoietic Stem Cell Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma
Not yet recruiting
- Double-Expressor Lymphoma
- +3 more
- Cyclophosphamide
- +6 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 27, 2022
Periampullary Cancer, Biliary Obstruction, Preoperative Biliary Drainage Trial (Preoperative Biliary Drainage (PBD), Surgery)
Completed
- Periampullary Cancer
- +2 more
- Preoperative Biliary Drainage (PBD)
- Surgery
- (no location specified)
Feb 27, 2020
Cephalosporin Resistance and Surgical Site Infections in
Completed
- Surgical Site Infection
- +2 more
- Preoperative biliary drainage
-
Helsinki, FinlandHelsinki Central Hospital
Oct 14, 2022
Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Worldwide (Camidanlumab Tesirine)
Active, not recruiting
- Relapsed Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- Camidanlumab Tesirine
-
Scottsdale, Arizona
- +72 more
Dec 15, 2022
Dental Implant Failure Nos, Alveolar Bone Loss, Peri-Implantitis Trial in Kafr Ash Shaykh (autogenous tooth graft, autogenous
Completed
- Dental Implant Failure Nos
- +2 more
- autogenous tooth graft
- autogenous bone graft
-
Kafr Ash Shaykh, Kafrelsheikh, Egyptfaculty of dentistry, kafrelsheikh University
Nov 17, 2023
Gastric Stenosis Trial in Baltimore (Endoscopic pneumatic balloon dilation, Gastric peroral endoscopic myotomy (G-POEM),
Recruiting
- Gastric Stenosis
- Endoscopic pneumatic balloon dilation
- +2 more
-
Baltimore, MarylandJohns Hopkins University
Jul 26, 2022
Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content, Head Neck Cancer Squamous Cell Carcinoma, NSCLC Trial in
Recruiting
- Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content
- +12 more
- ADCT-301
- Pembrolizumab
-
Palo Alto, California
- +9 more
Mar 24, 2022
Patients Undergoing Percutaneous Biliary Drainage
Active, not recruiting
- Malignant Biliary Obstruction
- FACT-Hep
-
Basking Ridge, New Jersey
- +4 more
Aug 8, 2022
Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)
Not yet recruiting
- Neuroendocrine Carcinomas
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 22, 2023
Early Alzheimers Disease, Mild Cognitive Impairment Due to AD Trial in Worldwide (PQ912, Placebo)
Active, not recruiting
- Early Alzheimers Disease
- Mild Cognitive Impairment Due to AD
- PQ912
- Placebo
-
Ganderup, Denmark
- +20 more
Dec 23, 2022
Diffuse Large B-cell Lymphoma Trial in United States (Loncastuximab Tesirine, Rituximab)
Recruiting
- Diffuse Large B-cell Lymphoma
- Loncastuximab Tesirine
- Rituximab
-
Reno, Nevada
- +4 more
Jul 1, 2022
Multiple Myeloma, Refractory Trial in Washington, Hackensack, Neptune (Pembrolizumab, Belantamab mafodotin, Dexamethasone)
Not yet recruiting
- Multiple Myeloma, Refractory
- Pembrolizumab
- +2 more
-
Washington, District of Columbia
- +2 more
Aug 5, 2022
Zellweger Syndrome, Peroxisome Biogenesis Disorders Trial in Toronto (Hydroxychloroquine, Placebo)
Completed
- Zellweger Syndrome
- Peroxisome Biogenesis Disorders
- Hydroxychloroquine
- Placebo
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Dec 15, 2020
Score in Matched Unrelated or Haploidentical Hematopoietic Stem
Completed
- Hematopoietic Stem Cell Transplantation
- +2 more
-
Saint Louis, Missouri
- +3 more
Feb 2, 2021